PD Dr. med. Dr. rer. nat. Christoph Hammers

Department of Dermatology, Allergy, and Venereology

Universitätsklinikum Schleswig-Holstein
Ratzeburger Allee 160
23538 Lübeck

Email:christoph.hammers(at)uksh.de
Phone:+49 451 500 50887
Fax:

Publikationen

1. Emtenani S, Ghorbanalipoor S, Mayer-Hain S, Kridin K, Komorowski L, Probst C, Hashimoto T, Pas HH, Meçińska-Jundzill K, Czajkowski R, Recke A, Sunderkötter C, Schneider SW, Hundt JE, Zillikens D, Schmidt E, Ludwig RJ, Hammers CM. Pathogenic activation and therapeutic blockage of Fc alpha receptor-expressing polymorphonuclear leukocytes in IgA pemphigus. J Invest Dermatol 2021; in press (accepted June 4, 2021)

2. Boch K*, Hammers CM*, Goletz S*, Kamaguchi M, Ludwig RJ, Schneider SW, Zillikens D, Hadaschik E, Schmidt E. IgM pemphigoid. J Am Acad Dermatol 2021; online ahead of print 3. Shimanovich I, Baumann T, Schmidt E, Zillikens D, Hammers CM. Long-term outcomes of rituximab therapy in pemphigus. J Eur Acad Dermatol Venereol 2020; 34:2884-2889

4. Gutjahr A, Heck F, Emtenani S, Hammers AK, Hundt JE, Muck P, Siegel DL, Schmidt E, Stanley JR, Zillikens D, Hammers CM. Bullous pemphigoid autoantibody-mediated complement fixation is abolished by the low-molecular-weight heparin tinzaparin sodium. Br J Dermatol 2019;181:593-594

5. Emtenani S*, Yuan H*, Lin C, Pan M, Hundt JE, Schmidt E, Komorowski L, Stanley JR*, Hammers CM*. Normal human skin is superior to monkey esophagus for detection of circulating BP180-NC16A-specific immunoglobulin G antibodies in bullous pemphigoid. Br J Dermatol 2019; 180:1099-1106 *equally contributing

6. Chen J*, Zheng Q*, Hammers CM, Ellebrecht CT, Mukherjee EM, Tang H, Lin C, Yuan H, Pan M, Langenhan J, Komorowski L, Siegel DL, Payne AS, Stanley JR. Proteomic Analysis of Pemphigus Autoantibodies Indicates a Larger, More Diverse, and More Dynamic Repertoire than Determined by B Cell Genetics. Cell Rep 2017; 18:237-247

7. Cho MJ, Ellebrecht CT, Hammers CM, Mukherjee EM, Sapparapu G, Boudreaux CE, McDonald SM, Crowe Jr JE, Payne AS. Determinants of VH1-46 cross-reactivity to pemphigus vulgaris autoantigen desmoglein 3 and rotavirus antigen VP6. J Immunol 2016; 197:1065-73

8. Hammers CM, Chen J, Lin C, Kacir S, Siegel DL, Payne AS, Stanley JR. Persistence of Anti-Desmoglein 3 IgG+ B-Cell Clones in Pemphigus Patients Over Years. J Invest Dermatol 2015; 135:742-9

9. Cho MJ, Lo AS, Mao X, Nagler AR, Ellebrecht CT, Mukherjee EM, Hammers CM, Choi EJ, Sharma PM, Uduman M, Li H, Rux AH, Farber SA, Rubin CB, Kleinstein SH, Sachais BS, Posner MR, Cavacini LA, Payne AS. Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients. Nat Commun 2014; 5:4167

10. Hammers CM, Bieber K, Kalies K, Banczyk D, Ellebrecht CT, Ibrahim SM, Zillikens D, Ludwig RJ, Westermann J. Complement‐Fixing Anti‐Type VII Collagen Antibodies Are Induced in Th1‐Polarized Lymph Nodes of Epidermolysis Bullosa Acquisita‐Susceptible Mice. J Immunol 2011;187:5043‐5050

*=these authors contributed equally to the work